Status:
COMPLETED
Technological Innovations in Behavioral Treatments for Cigarette Smoking
Lead Sponsor:
National Development and Research Institutes, Inc.
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.
Detailed Description
Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by ...
Eligibility Criteria
Inclusion
- Self-reported smoker
- Permission to contact applicant by phone
- Ability to use the internet
Exclusion
- Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00926939
Start Date
June 1 2009
End Date
August 1 2014
Last Update
April 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Development and Research Institutes
New York, New York, United States, 10010